feed,title,long_url,short_url
MedRxiv,Pulmonary function and survival one year after dupilumab treatment of acute moderate to severe COVID-19: A follow up study from a Phase IIa trial,https://medrxiv.org/cgi/content/short/2023.09.01.23293947v1?rss=1,https://da.gd/7AlJ0
